盤後時段
|
||||
|
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.97/5.98
|
|
企業價值
21.42B
|
| 資產負債 |
|
每股賬面淨值
-1.52
|
| 現金流量 |
|
現金流量率
0.60
|
| 損益表 |
|
收益
823.72M
|
|
每股收益
23.05
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘:2025/11/07 18:37 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reportsrevenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |

6.6 
